A pair of San Antonio biotech companies, BioBridge Global and StemBioSys Inc., have agreed to expand the scope of their collaborative relationship in an effort to bring a new source of stem cells to the research market.
Recent Posts
- Stem cell therapy linked to lower risk of heart failure after a heart attack
- Embryo-Like ‘Blood Factories’ Could One Day Supplement Donations
- Long-Term Growth Hormone Therapy Boosts Pediatric Stem Cells
- New UCLA drug could restore heart and organ function
- Parkinson’s treatment tested at UW showing promise in first clinical trial
- Scientists Create Early Human Embryos From Skin Cells And Sperm

